CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction.
about
The endocannabinoid system as an emerging target of pharmacotherapyPharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicityAnandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptorsEndocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusionsBlood pressure regulation by endocannabinoids and their receptorsCannabinoid receptors in acute and chronic complications of atherosclerosis.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningCardiovascular pharmacology of cannabinoids.CB1 cannabinoid receptor inhibition: promising approach for heart failure?Endocannabinoids and cardiac contractile function: pathophysiological implications.Endocannabinoids and the heart.The emerging role of the endocannabinoid system in cardiovascular disease.The potential for clinical use of cannabinoids in treatment of cardiovascular diseases.Fatty acids and cardiac disease: fuel carrying a message.Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists.Cannabinoid signaling in health and disease.Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction?Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model.Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice.
P2860
Q24648473-E70DBF26-6816-4AC7-9E27-68FE316387E8Q24648835-71F0E8DE-EE95-4E3A-95C1-5B7FAC672AB4Q35213727-6A54AC2F-4601-43E2-8E99-BE13BA913C12Q35228889-C8785C72-7241-4AFA-8BA7-770227964939Q35684044-801F93A9-0842-4468-8088-12BFD490836CQ36052772-00A7F71F-DBDB-44F0-9383-F1FC1E8A1E90Q36135785-436E583D-A167-47C4-BC41-C04F8AF8549BQ36416368-408DA69F-8875-4FF2-A4CF-CBBBA5B5146CQ36416372-4E7DC629-352F-4BC3-A5FD-ECEB85FD6B3DQ36431860-8A9ECF08-683B-4951-B28F-1417DB975301Q37160279-2F6D3B1D-A7DA-4BC3-A980-00AD3FD18BB3Q37401757-D28291C6-A341-483F-B4FD-C7D202412403Q37412217-760C286C-122B-4D1D-AAD3-CEDDED80F89CQ37439386-978597DE-9FB2-4D1D-B95D-3AA7FF55957DQ37800142-D2D4A7CA-C31D-4D39-A5A9-12B3CB0EB981Q38207743-93090A0C-A179-4EA4-82B5-2144789760FAQ38612812-BB34ADE0-9F89-4094-A982-5C56C1F17230Q39163671-4F7D40CF-0781-4828-B254-DB5F3BC5BD7FQ43263467-1A1B4844-378A-4A93-A66C-B2FD5FA646ACQ46171847-53ED22E3-91FF-44DD-BA8B-BCED51F271E5Q46985556-FA888BE2-0374-4349-8E66-81C191E1644AQ54572183-AB4B3622-68DC-4909-A141-733B1177AF13
P2860
CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
CB(1) cannabinoid receptor ant ...... ts with myocardial infarction.
@ast
CB(1) cannabinoid receptor ant ...... ts with myocardial infarction.
@en
type
label
CB(1) cannabinoid receptor ant ...... ts with myocardial infarction.
@ast
CB(1) cannabinoid receptor ant ...... ts with myocardial infarction.
@en
prefLabel
CB(1) cannabinoid receptor ant ...... ts with myocardial infarction.
@ast
CB(1) cannabinoid receptor ant ...... ts with myocardial infarction.
@en
P2093
P2860
P921
P356
P1476
CB(1) cannabinoid receptor ant ...... ts with myocardial infarction.
@en
P2093
Andreas Schäfer
Georg Ertl
Jan Karcher
Jens A Wagner
Johann Bauersachs
Martin Laser
P2860
P304
P356
10.1038/SJ.BJP.0705156
P407
P577
2003-04-01T00:00:00Z